This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Wall Street Analysts Predict a 27.74% Upside in TSS (TSSI): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 27.7% in TSS (TSSI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
2 Stocks in Focus From New Analyst Coverage Amid Uncertainty
by Shrabana Mukherjee
Fresh analyst coverage spotlights CBAN and TSSI as investors hunt opportunities amid volatility, with earnings outlooks and sharp recent stock moves drawing attention.
TSS Q3 Earnings & Revenues Fall Y/Y Even As 2026 Outlook Improves
by Zacks Equity Research
TSSI shares plunge after a weak Q3 earnings, but rising AI demand, stronger operations and upbeat guidance suggest growth may accelerate in 2026.
Revisiting 5 Small Cap AI Stocks: Still Buys?
by Tracey Ryniec
Mark Zinski, Zacks Small Cap Stock Analyst, returns to review AI stocks from prior podcast episodes.
Is TSSI Still Worth Buying After Surging 176.3% in the Past Year?
by Zacks Equity Research
TSS soars on 410% revenue growth, AI-fueled demand and a new facility built to scale next-gen infrastructure.
The Zacks Analyst Blog Highlights Bank of America, Roche, Intuit and TSS
by Zacks Equity Research
BAC, RHHBY, INTU and TSSI post varied growth stories, from AI-driven expansion to drug pipeline gains and digital revenue momentum.
Top Research Reports for Bank of America, Roche & Intuit
by Mark Vickery
Zacks highlights research on Bank of America, Roche, Intuit, and microcap TSS, noting growth opportunities despite mixed industry trends.
2 Outperform Rated Small Caps with Recent Pull-backs
by Mark Zinski
ELTP and TSSI are growth stories with recent material pull-backs.
TSS Posts Flat Y/Y Q2 Earnings, Raises Guidance on AI Growth
by Zacks Equity Research
After Q2 results, TSSI shares fall 23.7% as revenues jump 262% and EPS remains flat. Mix pressures margins, but management raises the 2025 EBITDA guidance on AI demand.
The Zacks Analyst Blog Highlights Wells Fargo, Abbott Laboratories, American Express, TSS and Maui Land & Pineapple
by Zacks Equity Research
Wells Fargo, Abbott, and American Express lead Zacks highlights, while TSS surges on AI growth and MLP eyes land monetization.